In the BrM/Glioma group, 8 DEPs (PRL, SNCA, MACF1, ACAT2, VWF, GSN, FCGBP, and F10) were selected for ROC curve analysis based on a logistic regression model. This evidence concerns the gene SNCA and central nervous system cancer.